Quarterly report [Sections 13 or 15(d)]

Consolidated Condensed Statements of Operations

v3.26.3
Consolidated Condensed Statements of Operations - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Sep. 26, 2026
Sep. 27, 2025
Sep. 26, 2026
Sep. 27, 2025
Income Statement [Abstract]        
Net revenue $ 16,513 $ 13,653 $ 46,218 $ 39,179
Cost of sales 9,417 8,435 27,266 25,747
Gross profit 7,096 5,218 18,952 13,432
Research and development 3,490 3,231 10,233 10,555
Marketing, general, and administrative 1,030 1,129 3,243 3,450
Restructuring and other charges 54 175 4,294 2,221
Operating expenses 4,574 4,535 17,770 16,226
Operating income (loss) 2,522 683 1,182 (2,794)
Gains (losses) on equity investments, net 330 221 219 611
Interest and other, net 1,130 3,670 (12,184) 3,402
Income (loss) before taxes 3,982 4,574 (10,783) 1,219
Provision for (benefit from) taxes 462 304 826 860
Net income (loss) 3,520 4,270 (11,609) 359
Less: net income (loss) attributable to non-controlling interests 200 207 (168) 35
Net income (loss) attributable to Intel $ 3,320 $ 4,063 $ (11,441) $ 324
Earnings (loss) per share attributable to Intel—basic (in dollars per share) $ 0.63 $ 0.90 $ (2.22) $ 0.07
Earnings (loss) per share attributable to Intel—diluted (in dollars per share) [1] $ 0.60 $ 0.90 $ (2.22) $ 0.07
Weighted average shares of common stock outstanding:        
Basic (in shares) 5,244 4,514 5,144 4,424
Diluted (in shares) 5,307 4,531 5,144 4,434
[1] For the three months ended September 26, 2026 and three and nine months ended September 27, 2025, earnings per share attributable to Intel-diluted has been calculated by adjusting net income attributable to Intel for the gain of $120 million and loss of $2 million, respectively, related to the mark-to-market of that portion of the derivative liability that is attributable to 5 million and 342 thousand, respectively, contingent Escrowed Shares that were included in the weighted average shares of common stock outstanding-diluted during the period.